MENU

Public Relations

Coverage

FY2026

You can scroll horizontally.

No. Date Media Broadcasting channel
Newspaper, journal		 Headline, title Page
24 4/24/2026 Web Science Japan iCONM develops new technology — Drug discovery target screening without cells  
23 4/24/2026 Newspaper Kagaku Shimbun Small antibodies act as a physical barrier, blocking the injection of “Pseudomonas aeruginosa needle” toxin p.4
22 4/23/2026 Web 客観日本 (Chinese) iCONM开发出无需细胞的药物靶点筛选技术，定量性、灵活性与开发速度均大幅提升  
21 4/21/2026 Web/Magazine iNewsletter Spring Issue Toward clinical testing that does not require blood draws p.2
20 4/16/2026 Web Sekolar Farmasi, Inst. Tech. Bandun Perkuat Kolaborasi Nanomedicine Global, SF ITB Jajaki Kolaborasi dengan Innovation Center of NanoMedicine (ICONM)  
19 4/15/2026 Magazine/Web Iyaku-Keizai Practitioner of Medical-Engineering Collaboration #161: A New Selection Method for Evolutionary Molecular Drug Discovery p.26
18 4/14/2026 Web First Word Pharma Surface charge and membrane lipid composition define extracellular vesicle (EV) function: Lipid asymmetry enables new quality metrics for EV-based therapeutics  
17 4/14/2026 Web Phys.Org. Phospholipid asymmetry helps explain extracellular vesicle surface charge and therapeutic quality  
16 4/14/2026 Web Bioengineer.org How Surface Charge and Membrane Lipid Composition Shape Extracellular Vesicle Function: Lipid Asymmetry Unlocks Novel Quality Metrics for EV-Based Therapeutics  
15 4/14/2026 Web EurekAlert! In Japanese Surface charge and membrane lipid composition define extracellular vesicle (EV) function: Lipid asymmetry enables new quality metrics for EV-based therapeutics  
14 4/14/2026 Web EurekAlert! Surface charge and membrane lipid composition define extracellular vesicle (EV) function: Lipid asymmetry enables new quality metrics for EV-based therapeutics  
13 4/10/2026 Web Nippon-no Kenkyu.com mRNA creates “tiny antibodies” within the body to protect it from bacterial toxins—Next-generation antibody therapy using messenger RNA to tackle the threat of multidrug-resistant bacteria—  
12 4/10/2026 Web Mainichi Shimbun Web mRNA Technology Proves Effective in Treating Drug-Resistant Bacteria  
11 4/10/2026 Newspaper Nikkan Kogyo Shumbun Development of treatments for drug-resistant bacteria p.17
10 4/9/2026 Newspaper Kyoto Shimbun Experiments Confirm Treatment for Multidrug-Resistant Bacteria—Could Deaths from These Bacteria Surpass Those from Cancer in the Future? Hopes for Application Against Drug-Resistant Bacteria  
9 4/9/2026 Web Mainichi Shimbun Web Developing “Small Antibodies” Using mRNA to Treat Bacterial Infections  
8 4/6/2026 Web BlackBox iCONM: Where the Future Biotech Takes Shape  
7 4/6/2026 Web Nikkei Biotech NANO MRNA、Signed a Memorandum of Understanding to Acquire Luna RD, a Next-Generation LNP Technology Startup  
6 4/2/2026 Newspaper Fukushima Minyu News Masamichi Chino has been appointed Division Director of F-REI, and Takuro Shinano has been appointed Principal Investigator  
5 4/1/2026 Web Kawasaki Coastal Area Supplementary Reader for Junior High School King SkyFront Research Institute ①: Innovation Center of NanoMedicine  
4 4/1/2026 Web Kawasaki Coastal Area Supplementary Reader for Elementary School King SkyFront Research Institute ①: Innovation Center of NanoMedicine  
3 4/1/2026 Web/Magazine Kawasaki City Statistical Yearbook 2026　"Kawasaki-no-koto" The Day the In-Body Hospitals Save You: A World-First Challenge Using Nanomachines p.8
2 4/1/2026 Web/Magazine KNA News #120 Preferable hospitals like this p.6
1 4/1/2026 Web/Magazine Sangyo Joho Kawasaki April Issue iCONM Column㉙　As We Begin the New Fiscal Year: 20 Years Until the Realization of the “In-Bbody Hospitals" p.4